RECURRENT LYMPHOMA
Clinical trials for RECURRENT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LYMPHOMA trials appear
Sign up with your email to follow new studies for RECURRENT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vitamin c boost: could high doses make chemo work better for tough blood cancers?
Disease control Recruiting nowThis study tests whether adding high-dose vitamin C to standard chemotherapy can help treat blood cancers like lymphoma and chronic myelomonocytic leukemia (CMML) that have returned or not responded to treatment. About 80 adults will receive the combination therapy. The goal is t…
Matched conditions: RECURRENT LYMPHOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 04:01 UTC
-
New hope for kids with relapsed cancers: experimental drug CBL0137 enters trials
Disease control Recruiting nowThis study tests an experimental drug called CBL0137 in children and young adults (ages 1 to 21) whose solid tumors, brain tumors, or lymphoma have returned or stopped responding to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors by …
Matched conditions: RECURRENT LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 13, 2026 15:58 UTC